Mounjaro Maker Eli Lilly Clocks 45% Jump In Q1 Revenue, Cuts 2025 Profit Outlook But Not Due To Tariffs
benzinga.com/general/biotech/25/05/45136276/mounjaro-maker-eli-lilly-clocks-45-jump-in-q1-revenue-cuts-2025-profit-outlook-but-not-due-to-tar
Eli Lilly and Co (NYSE:LLY) stock is trading lower after the company released first-quarter earnings and lowered 2025 guidance.
The U.S. pharma giant reported first-quarter revenue of $12.73 billion, up 45% year over year, almost in line with the consensus of $12.67 billion, driven by a…
This story appeared on benzinga.com, 2025-05-01 13:42:38.